Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stone

Showing results (111-120 of 2,546) with videos related to

Pageof 255
Sort By:
Seminars in Hematology|September 6, 2002
Treatment of acute myeloid leukemia: state-of-the-art and future directionsRichard M Stone
Hospitals & Health Networks|September 28, 2001
Another tech 'must'R M Stone
Health Communication|October 19, 2018
Communication and bioethics at the end of life: real cases, real dilemmasAnne M Stone
Leukemia|March 21, 2003
Induction and postremission therapy: new agentsR M Stone
British Journal of Clinical Pharmacology|January 1, 1984
Pencil and paper tests--sensitivity to psychotropic drugsB M Stone
American Journal of Ophthalmology|October 30, 2007
Leber congenital amaurosis - a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial LectureEdwin M Stone
The American Journal of Orthopsychiatry|January 1, 1992
The role of shame in post-traumatic stress disorderA M Stone
Best Practice & Research. Clinical Haematology|December 2, 2008
Are new agents really making a difference in MDS?Richard M Stone
The Annals of Applied Biology|January 1, 1973
The elimination of viruses from Narcissus tazetta cv. Grand Soleil d'Or, and rapid multiplication of virus-free clonesO M Stone
Best Practice & Research. Clinical Haematology|December 1, 2011
Should the presence of minimal residual disease (MRD) in morphologic complete remission alter post-remission strategy in AML?Richard M Stone
Pageof 255

Showing results (111-120 of 2,546) with videos related to

Sort By:
Pageof 255
Seminars in Hematology|September 6, 2002
Treatment of acute myeloid leukemia: state-of-the-art and future directionsRichard M Stone
Hospitals & Health Networks|September 28, 2001
Another tech 'must'R M Stone
Health Communication|October 19, 2018
Communication and bioethics at the end of life: real cases, real dilemmasAnne M Stone
Leukemia|March 21, 2003
Induction and postremission therapy: new agentsR M Stone
British Journal of Clinical Pharmacology|January 1, 1984
Pencil and paper tests--sensitivity to psychotropic drugsB M Stone
American Journal of Ophthalmology|October 30, 2007
Leber congenital amaurosis - a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial LectureEdwin M Stone
The American Journal of Orthopsychiatry|January 1, 1992
The role of shame in post-traumatic stress disorderA M Stone
Best Practice & Research. Clinical Haematology|December 2, 2008
Are new agents really making a difference in MDS?Richard M Stone
The Annals of Applied Biology|January 1, 1973
The elimination of viruses from Narcissus tazetta cv. Grand Soleil d'Or, and rapid multiplication of virus-free clonesO M Stone
Best Practice & Research. Clinical Haematology|December 1, 2011
Should the presence of minimal residual disease (MRD) in morphologic complete remission alter post-remission strategy in AML?Richard M Stone
Pageof 255